Accelerated AGEing: The Impact of Advanced Glycation end Products on the Prognosis of Chronic Kidney Disease

Elena Dozio,Lara Caldiroli,Paolo Molinari,Giuseppe Castellano,Nicholas Walter Delfrate,Massimiliano Marco Corsi Romanelli,Simone Vettoretti
DOI: https://doi.org/10.3390/antiox12030584
IF: 7.675
2023-02-27
Antioxidants
Abstract:Advanced glycation end products (AGEs) are aging products. In chronic kidney disease (CKD), AGEs accumulate due to the increased production, reduced excretion, and the imbalance between oxidant/antioxidant capacities. CKD is therefore a model of aging. The aim of this review is to summarize the present knowledge of AGEs in CKD onset and progression, also focusing on CKD-related disorders (cardiovascular diseases, sarcopenia, and nutritional imbalance) and CKD mortality. The role of AGEs as etiopathogenetic molecules, as well as potential markers of disease progression and/or therapeutic targets, will be discussed.
biochemistry & molecular biology,chemistry, medicinal,food science & technology
What problem does this paper attempt to address?